|
1
|
Geng F, Wang Z, Yin H, Yu J and Cao B:
Molecular targeted drugs and treatment of colorectal cancer: Recent
progress and future perspectives. Cancer Biother Radiopharm.
32:149–160. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fang JY, Dong HL, Sang XJ, Xie B, Wu KS,
Du PL, Xu ZX, Jia XY and Lin K: Colorectal cancer mortality
characteristics and predictions in China, 1991–2011. Asian Pac J
Cancer Prev. 16:7991–7995. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gu MJ, Huang QC, Bao CZ, Li YJ, Li XQ, Ye
D, Ye ZH, Chen K and Wang JB: Attributable causes of colorectal
cancer in China. BMC Cancer. 18:382018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun L, Xue H, Jiang C, Zhou H, Gu L, Liu
Y, Xu C and Xu Q: LncRNA DQ786243 contributes to proliferation and
metastasis of colorectal cancer both in vitro and in vivo. Biosci
Rep. 36:e003282016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Strubberg AM and Madison BB: MicroRNAs in
the etiology of colorectal cancer: Pathways and clinical
implications. Dis Model Mech. 10:197–214. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu W, Yang P, Feng X, Wang H, Qiu Y, Tian
T, He Y, Yu C, Yang J, Ye S and Zhou Y: The relationship between
and clinical signifcance of microRNA-32 and phosphatase and tensin
homologue expression in colorectal cancer. Genes Chromosomes
Cancer. 52:1130–1140. 2013. View Article : Google Scholar
|
|
8
|
Wu W, Yang J, Feng X, Wang H, Ye S, Yang
P, Tan W, Wei G and Zhou Y: MicroRNA-32 (miR-32) regulates
phosphatase and tensin homologue (PTEN) expression and promotes
growth, migration, and invasion in colorectal carcinoma cells. Mol
Cancer. 12:302013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu W, Tan W, Ye S, Zhou Y and Quan J:
Analysis of the promoter region of the human miR-32 gene in
colorectal cancer. Oncol Lett. 17:3743–3750. 2019.PubMed/NCBI
|
|
10
|
Li L, Gong M, Zhao Y, Zhao X and Li Q:
FOXK1 facilitates cell proliferation through regulating the
expression of p21, and promotes metastasis in ovarian cancer.
Oncotarget. 8:70441–70451. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen D, Wang K, Li X, Jiang M, Ni L, Xu B,
Chu Y, Wang W, Wang H, Kang H, et al: FOXK1 plays an oncogenic role
in the development of esophageal cancer. Biochem Biophys Res
Commun. 494:88–94. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu Y, Peng Y, Wu M, Zhang W, Zhang M, Xie
R, Zhang P, Bai Y, Zhao J, Li A, et al: Oncogene FOXK1 enhances
invasion of colorectal carcinoma by inducing epithelial-mesenchymal
transition. Oncotarget. 7:51150–51162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ayyar K and Reddy KVR: Transcription
factor CCAAT/enhancer-binding protein-β upregulates microRNA,
let-7f-1 in human endocervical cells. Am J Reprod Immunol. 78:Epub
2017. Sep 16–2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gulyaeva LF and Kushlinskiy NE: Regulatory
mechanisms of microRNA expression. J Transl Med. 14:1432016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Treiber T, Treiber N, Plessmann U,
Harlander S, Daiß JL, Eichner N, Lehmann G, Schall K, Urlaub H and
Meister G: A compendium of RNA-binding proteins that regulate
microRNA biogenesis. Mol Cell. 66:270–284.e13. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Scisciani C, Vossio S, Guerrieri F,
Schinzari V, De Iaco R, D'Onorio de Meo P, Cervello M, Montalto G,
Pollicino T, Raimondo G, et al: Transcriptional regulation of
miR-224 upregulated in human HCCs by NFκB inflammatory pathways. J
Hepatol. 56:855–861. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koutalianos D, Koutsoulidou A,
Mastroyiannopoulos NP, Furling D and Phylactou LA: MyoD
transcription factor induces myogenesis by inhibiting Twist-1
through miR-206. J Cell Sci. 128:3631–3645. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dodd RD, Sachdeva M, Mito JK, Eward WC,
Brigman BE, Ma Y, Dodd L, Kim Y, Lev D and Kirsch DG: Myogenic
transcription factors regulate pro-metastatic miR-182. Oncogene.
35:1868–1875. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang HM, Kuang S, Xiong X, Gao T, Liu C
and Guo AY: Transcription factor and microRNA co-regulatory loops:
Important regulatory motifs in biological processes and diseases.
Brief Bioinform. 16:45–58. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baskerville S and Bartel DP: Microarray
profiling of microRNAs reveals frequent coexpression with
neighboring miRNAs and host genes. RNA. 11:241–247. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lerner M, Harada M, Lovén J, Castro J,
Davis Z, Oscier D, Henriksson M, Sangfelt O, Grandér D and Corcoran
MM: DLEU2, frequently deleted in malignancy, functions as a
critical host gene of the cell cycle inhibitory microRNAs miR-15a
and miR-16-1. Exp Cell Re. 315:2941–2952. 2009. View Article : Google Scholar
|
|
23
|
Shao L, Chen Z, Peng D, Soutto M, Zhu S,
Bates A, Zhang S and El-Rifai W: Methylation of the HOXA10 promoter
directs miR-196b-5p-dependent cell proliferation and invasion of
gastric cancer cells. Mol Cancer Res. 16:696–706. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ambs S, Prueitt RL, Yi M, Hudson RS, Howe
TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, et al:
Genomic profiling of microRNA and messenger RNA reveals deregulated
microRNA expression in prostate cancer. Cancer Res. 68:6162–6170.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu Y, Ding W, Ge H, Ponnusamy M, Wang Q,
Hao X, Wu W, Zhang Y, Yu W, Ao X and Wang J: FOXK transcription
factors: Regulation and critical role in cancer. Cancer Lett.
458:1–12. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi X and Garry DJ: Sin3 interacts with
Foxk1 and regulates myogenic progenitors. Mol Cell Biochem.
366:251–258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sukonina V, Ma H, Zhang W, Bartesaghi S,
Subhash S, Heglind M, Foyn H, Betz MJ, Nilsson D, Lidell ME, et al:
FOXK1 and FOXK2 regulate aerobic glycolysis. Nature. 566:279–283.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sakaguchi M, Cai W, Wang CH, Cederquist
CT, Damasio M, Homan EP, Batista T, Ramirez AK, Gupta MK, Steger M,
et al: FoxK1 and FoxK2 in insulin regulation of cellular and
mitochondrial metabolism. Nat Commun. 10:15822019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li P, Yu Z, He L, Zhou D, Xie S, Hou H and
Geng X: Knockdown of FOXK1 inhibited the proliferation, migration
and invasion in hepatocellular carcinoma cells. Biomed
Pharmacother. 92:270–276. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu M, Wang J, Tang W, Zhan X, Li Y, Peng
Y, Huang X, Bai Y, Zhao J, Li A, et al: FOXK1 interaction with FHL2
promotes proliferation, invasion and metastasis in colorectal
cancer. Oncogenesis. 5:e2712016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang H, Wu X, Xiao Y, Wu L, Peng Y, Tang
W, Liu G, Sun Y, Wang J, Zhu H, et al: Coexpression of FOXK1 and
vimentin promotes EMT, migration, and invasion in gastric cancer
cells. J Mol Med (Berl). 97:163–176. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ji ZG, Jiang HT and Zhang PS: FOXK1
promotes cell growth through activating wnt/β-catenin pathway and
emerges as a novel target of miR-137 in glioma. Am J Transl Res.
10:1784–1792. 2018.PubMed/NCBI
|
|
33
|
Chen F, Xiong W, Dou K and Ran Q:
Knockdown of FOXK1 suppresses proliferation, migration, and
invasion in prostate cancer cells. Oncol Res. 25:1261–1267. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang X, Xiang L, Li Y, Zhao Y, Zhu H,
Xiao Y, Liu M, Wu X, Wang Z, Jiang P, et al: Snail/FOXK1/Cyr61
signaling axis regulates the epithelial-mesenchymal transition and
metastasis in colorectal cancer. Cell Physiol Biochem. 47:590–603.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang J, Liu G, Liu M, Xiang L, Xiao Y, Zhu
H, Wu X, Peng Y, Zhang W, Jiang P, et al: The FOXK1-CCDC43 axis
promotes the invasion and metastasis of colorectal cancer cells.
Cell Physiol Biochem. 51:2547–2563. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu H, Huang S, Zhu X, Zhang W and Zhang X:
FOXK1 promotes glioblastoma proliferation and metastasis through
activation of Snail transcription. Exp Ther Med. 15:3108–3116.
2018.PubMed/NCBI
|
|
37
|
Zhang Z, Li M and Zhang Z: LncRNA MALAT1
modulates oxaliplatin resistance of gastric cancer via sponging
miR-22-3p. Onco Targets Ther. 13:1343–1354. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang L and Ding F: Hsa_circ_0008945
promoted breast cancer progression by targeting miR-338-3p. Onco
Targets Ther. 12:6577–6589. 2019. View Article : Google Scholar : PubMed/NCBI
|
